First Trust NYSE Arca Biotechnology Index Fund Rating $165.53 +1.51 (+0.92%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.66Holdings in FBT have an aggregate rating of Moderate Buy based on 522 analyst ratings issued in the past year covering 30 companies (99.8% of the portfolio).FBT Aggregate Price Target$165.53High Prediction$165.53Average Prediction$165.53Low Prediction$165.53Holdings in FBT have an aggregate price target of $165.53 and a range of $165.53 to $165.53 covering 30 companies (99.8% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.47%EXELExelixis$33.29-1.2%4.4996 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume4.37%CORTCorcept Therapeutics$51.40+0.5%4.851 of 5 stars3.00$65.25 26.9%5Analyst RevisionHigh Trading Volume4.33%NTRANatera$161.88+2.4%1.8947 of 5 stars3.00$152.67 -5.7%15Positive NewsGap DownHigh Trading Volume3.76%ARGXargenx$623.82-0.4%2.995 of 5 stars2.91$639.78 2.6%22Analyst ForecastShort Interest ↓Positive News3.75%ITCIIntra-Cellular Therapies$83.45-0.8%4.0543 of 5 stars2.85$97.23 16.5%133.63%ACADACADIA Pharmaceuticals$16.87+0.8%3.7007 of 5 stars2.63$25.60 51.7%16High Trading Volume3.62%GILDGilead Sciences$92.57+1.6%4.4195 of 5 stars2.67$96.43 4.2%27Insider TradeHigh Trading Volume3.62%INCYIncyte$68.84+2.7%4.7108 of 5 stars2.35$76.29 10.8%20Analyst ForecastHigh Trading Volume3.61%NBIXNeurocrine Biosciences$135.42+0.3%4.8318 of 5 stars2.83$166.00 22.6%23Analyst ForecastInsider TradeHigh Trading Volume3.60%WATWaters$368.16+2.1%3.7105 of 5 stars2.29$375.85 2.1%14High Trading Volume3.58%CPRXCatalyst Pharmaceuticals$21.27-0.9%4.7458 of 5 stars3.00$31.14 46.4%73.56%RGENRepligen$144.46-1.4%4.097 of 5 stars2.62$185.20 28.2%13Analyst ForecastHigh Trading Volume3.43%UTHRUnited Therapeutics$359.58-0.2%4.7079 of 5 stars2.73$370.86 3.1%15Analyst DowngradeInsider TradeHigh Trading Volume3.39%ALKSAlkermes$29.71-0.9%4.6622 of 5 stars2.58$35.42 19.2%12Positive NewsHigh Trading Volume3.37%SRPTSarepta Therapeutics$118.97-0.4%4.8162 of 5 stars2.91$178.71 50.2%22Analyst ForecastPositive News3.21%ILMNIllumina$136.02+1.5%4.4818 of 5 stars2.70$165.95 22.0%20High Trading Volume3.19%BNTXBioNTech$113.08+1.6%2.027 of 5 stars2.82$140.76 24.5%173.16%VRTXVertex Pharmaceuticals$397.27+0.2%4.7494 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume3.07%GMABGenmab A/S$20.31+1.1%4.2467 of 5 stars2.56$45.20 122.6%9High Trading Volume3.04%HALOHalozyme Therapeutics$46.96-0.8%4.9904 of 5 stars2.60$61.11 30.1%10Analyst ForecastPositive NewsHigh Trading Volume2.99%BMRNBioMarin Pharmaceutical$65.66+1.0%4.9837 of 5 stars2.74$94.20 43.5%23Positive NewsHigh Trading Volume2.97%BRKRBruker$57.00+3.1%4.9911 of 5 stars2.58$74.45 30.6%12Analyst ForecastHigh Trading Volume2.95%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.416 of 5 stars2.71$298.09 21.5%24Analyst Upgrade2.90%BGNEBeiGene$176.50+1.0%2.6104 of 5 stars2.75$253.69 43.7%82.88%MTDMettler-Toledo International$1,230.74+2.0%3.9279 of 5 stars2.00$1,351.25 9.8%9High Trading Volume2.84%BIIBBiogen$146.47-0.6%4.6279 of 5 stars2.45$242.68 65.7%29Analyst DowngradeHigh Trading Volume2.84%EXASExact Sciences$59.40+5.9%4.5271 of 5 stars2.94$72.94 22.8%182.82%AMGNAmgen$263.38+0.8%4.4625 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume2.46%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6604 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume2.43%MRNAModerna$39.39-0.4%4.2751 of 5 stars2.14$79.50 101.8%22Analyst DowngradeHigh Trading Volume This page (NYSEARCA:FBT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
